SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern

Anupriya Aggarwal, Anouschka Akerman, Vanessa Milogiannakis, Mariana Ruiz Silva, Gregory Walker, Andrea Kidinger, Thomas Angelovich, Emily Waring, Supavadee Amatayakul-Chantler, Nathan Roth, Germano Coppola, Malinna Yeang, Tyra Jean, Charles Foster, Alexandra Carey Hoppe, C. Mee Ling Munier, David Darley, Melissa Churchill, Damian Starck, Daniel Christ, Gail Matthews, William Rawlinson, Anthony D. Kelleher, Stuart Turville
doi: https://doi.org/10.1101/2022.07.07.22277128

Data Availability

All data produced in the present study are available upon reasonable request to the authors. Upon publication we will provide data through Figshare

Back to top
Posted July 10, 2022.
Download PDF

Supplementary Material

Data/Code
Email
SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern
Anupriya Aggarwal, Anouschka Akerman, Vanessa Milogiannakis, Mariana Ruiz Silva, Gregory Walker, Andrea Kidinger, Thomas Angelovich, Emily Waring, Supavadee Amatayakul-Chantler, Nathan Roth, Germano Coppola, Malinna Yeang, Tyra Jean, Charles Foster, Alexandra Carey Hoppe, C. Mee Ling Munier, David Darley, Melissa Churchill, Damian Starck, Daniel Christ, Gail Matthews, William Rawlinson, Anthony D. Kelleher, Stuart Turville
medRxiv 2022.07.07.22277128; doi: https://doi.org/10.1101/2022.07.07.22277128
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area